Targeting inflammation to fight cancer is a new approach with a long history.

Read a patient’s perspective on living with a rare, life-threatening blood cancer called myelofibrosis and why it’s important to rally the community.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

Explaining Chagas disease through the stories of patients in Bolivia.

Jennifer Allport-Anderson hunts for cardiac cures.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Yan Zhao talks about how her team in China responded to an emerging public health crisis.

A new compound aims to attack dangerous antibiotic-resistant bacteria.